Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;40(31):3667-3668.
doi: 10.1200/JCO.22.01213. Epub 2022 Jul 5.

Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?

Affiliations
Comment

Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?

Julien Edeline et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Julien EdelineConsulting or Advisory Role: BTG, Bristol Myers Squibb, AstraZeneca, Bayer, Ipsen, AstraZeneca, MSD, Eisai, Boston Scientific, Roche, Basilea, Merck Serono, ServierResearch Funding: Bristol Myers Squibb (Inst), BeiGene (Inst)Travel, Accommodations, Expenses: Amgen, Bristol Myers Squibb, Roche David MalkaHonoraria: Roche, Amgen, Bayer, Merck Serono, Servier, Sanofi, Pierre Fabre, Viatris, Bristol Myers Squibb, MSD Oncology, LEO Pharma, Incyte, AstraZenecaConsulting or Advisory Role: Roche, Sanofi, Merck Serono, MSD, Servier, Bayer, Incyte, Amgen, Bristol Myers Squib, Taiho Oncology, AbbVie, AstraZeneca, Pierre FabreTravel, Accommodations, Expenses: Roche, Bayer, Sanofi, Merck Serono, Amgen, Servier, Pierre Fabre, Bristol Myers Squibb/Pfizer, MSD, ViatrisNo other potential conflicts of interest were reported.

Comment in

  • Reply to J. Edeline et al.
    Bridgewater J, Fletcher P, Primrose J; BILCAP Study Group. Bridgewater J, et al. J Clin Oncol. 2022 Nov 1;40(31):3668. doi: 10.1200/JCO.22.01283. Epub 2022 Jul 5. J Clin Oncol. 2022. PMID: 35787066 No abstract available.

Comment on

  • Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
    Bridgewater J, Fletcher P, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans TR, Stocken D, Stubbs C, Praseedom R, Ma YT, Davidson B, Neoptolemos J, Iveson T, Cunningham D, Garden OJ, Valle JW, Primrose J; BILCAP study group. Bridgewater J, et al. J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22. J Clin Oncol. 2022. PMID: 35316080 Clinical Trial.

MeSH terms

LinkOut - more resources